Chujie Bai
Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Dual Inhibition of LAG-3 and PD-1 with IBI110 and Sintilimab in Advanced Alveolar Soft Part Sarcoma: A Single-Center, Phase II Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 20, 2026
The efficacy and predictive value of 99mTc-rituximab for sentinel lymph node biopsy in acral melanoma patients.
Journal: World journal of surgical oncology
Published: February 24, 2026
Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial.
Journal: Journal for immunotherapy of cancer
Published: December 30, 2024
Targeting MCM2 activates cancer-associated fibroblasts-like phenotype and affects chemo-resistance of liposarcoma cells against doxorubicin.
Journal: Anti-cancer drugs
Published: August 07, 2024
Anlotinib plus TQB2450, a PD-L1 Antibody, in Patients with Advanced Alveolar Soft Part Sarcoma: A Single-Arm, Phase II Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 30, 2024
Self-assembled patient-derived tumor-like cell clusters for personalized drug testing in diverse sarcomas.
Journal: Cell reports. Medicine
Published: June 30, 2024
AOC3 accelerates lung metastasis of osteosarcoma by recruiting tumor-associated neutrophils, neutrophil extracellular trap formation and tumor vascularization.
Journal: Heliyon
Published: April 16, 2024
Comprehensive profiling of pathogenic germline large genomic rearrangements in a pan-cancer analysis.
Journal: Molecular oncology
Published: December 21, 2022
Specific gene module pair-based target identification and drug discovery.
Journal: Frontiers in pharmacology
Published: November 04, 2022
Clinical features and therapeutic outcomes of alveolar soft part sarcoma in children: A single-center, retrospective study.
Journal: Frontiers in oncology
Published: August 15, 2022
Efficacy of PD-1 inhibitors combined with pegylated liposomal doxorubicin and dacarbazine compared with liposomal doxorubicin and dacarbazine in advanced leiomyosarcoma patients: a retrospective, single-institutional cohort study.
Journal: Annals of translational medicine
Published: June 29, 2022
Last Updated: 09/26/2026